Published in Vaccine Weekly, April 22nd, 2009
"The vaccine was immunogenic and caused no adverse reactions. When monkeys were immunized with bacillus Calmette-Guerin ( BCG) and then boosted with Mtb72F in AS02A, protection superior to that afforded by using BCG alone was achieved, as measured by clinical parameters, pathology, and survival. We observed long-term survival and evidence of reversal of disease progression in monkeys...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly